Archives

by in
Entry Author Date Location
Dunsire Out at Millennium as Takeda Reorganizes, Cuts Costs 05/09/13 Boston
Celgene Wins FDA Approval of Third Myeloma Drug 02/08/13 New York
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting 12/07/12 Boston
GNS to Use Big Data to Fight Multiple Myeloma 11/08/12 Boston
Richard Brewer, Former Scios CEO and Dendreon Chairman, Dies at 61 08/15/12 San Francisco
Onyx Drug Effective in New Myeloma Patients, Taking Aim at Millennium 12/12/11 San Francisco
Epigenetic Drug Startup Tensha Therapeutics Snags $15M Series A 09/12/11 Boston
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs 08/22/11 National
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO 08/18/11 National
Onyx Unveils Results for Myeloma Drug, Raising Stakes in Rivalry with Millennium 12/07/10 San Francisco
Glaxo Ends Resveratrol Drug Study 12/01/10 Boston
Onyx Delays Cancer Drug Application as FDA Asks for More Data on Manufacturing 10/07/10 San Francisco
Onyx Pockets $59M Upfront From Japanese Partner, to Market Myeloma Drugs 09/08/10 San Francisco
LS9 Reveals Key Biofuel Genes, Onyx Drug Passes Big Trial, Solazyme Seeks First-Mover Edge, & More Bay Area Life Sciences News 07/30/10 San Francisco
Onyx Preps for Dash to FDA, After Myeloma Drug Helps Sickest of the Sick 07/26/10 San Francisco
Oncothyreon Stock Plummets as Side Effect Emerges in Cancer Patient, Trials Halted 03/23/10 Seattle
Roche Scraps Partnership With Seattle Genetics on Lymphoma Drug 12/11/09 Seattle
How Millennium Is Tapping A Harvard Lab to Help Discover New Cancer Drugs 11/24/09 Boston
Acceleron, Bucking Conventional Wisdom, Pushes Ahead Drug For Bone Loss, Anemia 09/11/09 Boston
$252M Potential in CLDA and CombinatoRx Deal 08/13/09 Boston
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner 08/07/09 Boston
Genzyme’s Mozobil Gets European Approval 08/05/09 Boston
Genzyme Wins FDA Approval of Mozobil 12/15/08 Boston
Blood News: A Quick Rundown of Headlines From the American Society of Hematology 12/09/08 National
Millennium’s Velcade, As Time Wears On, Shows Durable Ability to Prolong Lives 12/08/08 Boston
Biogen Turns Down Dying Patient’s Request For Tysabri—and Explains Why 10/14/08 Boston
Biogen Idec, Elan Start First Cancer Trial With Tysabri 09/05/08 Boston
Page 1 of 1

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.